Hybrid adaptive immunity to SARS-CoV-2 protects against breakthrough infection after COVID-19 vaccination in ALSPAC participants

Baum HE., Santopaolo M., Francis O., Milowdowski E., Entwistle K., Oliver E., Hitchings B., Diamond D., Thomas AC., Mitchell RE., Kibble M., Gupta K., Di Bartolo N., Klenerman P., Brown A., Morales-Aza B., Oliver J., Berger I., Toye AM., Finn A., Goenka A., Davidson AD., Ring S., Molloy L., Lewcock M., Northstone K., Roth F., Timpson NJ., Wooldridge L., Halliday A., Rivino L.

DOI

10.1101/2024.06.14.24308948

Type

Preprint

Publication Date

2024-08-08T00:00:00+00:00

Keywords

breakthrough infection, ALSPAC, SARS-CoV-2, COVID-19, adaptive immunity, T-cells, antibodies, vaccination, hybrid immunity, infection

Permalink More information Close